News
Regulatory NewsRegulatory Round-up - December 2024
October news: Spotlight on clinical adoption of advanced therapiesRegulatory News - September 2021Press Release: Quell Therapeutics significantly expands clinical manufacturing capacity for its engineered Treg cell therapies through a collaboration with the Cell and Gene Therapy CatapultPress Release: Dr John Brown, CBE to retire as Cell and Gene Therapy Catapult’s ChairmanPress Release: AAV reference material to be produced at the Cell and Gene Therapy Catapult Braintree in collaboration with the National Institute for Biological Standards and ControlSeptember news: Enhancing collaboration throughout the UK cell and gene therapy ecosystemRegulatory News - August 2021August news: Bolstering the UK cell and gene therapy industryJune news: Establishing collaborationsMay news: Developing pivotal solutions for cutting-edge cell and gene therapy researchRegulatory News - July 2021Innovative gene therapy programme paves the way for new treatments for neurodegenerative diseases